AHA 2018 Dapagliflozin was associated with a reduction in CVD/hospitalization in T2DM patients with ASCVD or with multiple risk factors, and with a modest decrease in MACE in those with existing ASCVD.
Download the Serbian version of the EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care.
The new guidelines on management of CVD during pregnancy consider new evidence on diagnostic techniques, risk assessment and drug therapy that became available since the 2012 edition.
EPCCS 2018 Management of heart failure is complex, as it often concerns elderly patients who have comorbidities. Good cooperation between primary and secondary care can benefit these patients.
A prospective study showed an inversed association between nut consumption and incidence of atrial fibrillation and heart failure in the Swedish population.
EPCCS 2018 A recording of the presentation byDr. Nuria Farré, who gave the specialist perspective in the discussion on how to best diagnose and monitor heart failure in primary care, and how to manage comorbidities.
EPCCS 2018 A recording of the presentation by Miguel Angel Muñoz, who gave the GP perspective in the discussion on how to best daignose and monitor heart failure in primary care, and how to manage comorbidities.
ESC 2018 In this debate, it became clear that not all are convinced yet about the use of the new ejection fraction category HFmrEF that was introduced in the latest ESC HF Guidelines in 2016.
ESC HF 2018 Playing of video games that require rigorous physical exercise yielded significant effects on exercise capacity and well-being in some HF patients.
ESC HF 2018 A large study on individual patient data shows that diabetic HF patients who are not obese have the highest mortality. Obesity attenuates the prognostic impact of beta-blockers.
Moderate and severe malnutrition in HF patients, assessed with simple malnutrition scores, was associated with higher all-cause mortality.
Electric and magnetic fields generated during operation and charging of electric cars did not affect the function or programming of cardiac implantable electronic devices.